期刊
JOURNAL OF PERINATAL MEDICINE
卷 43, 期 2, 页码 133-139出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/jpm-2014-0089
关键词
Fetal complications; intrahepatic cholestasis of pregnancy (ICP); intrauterine fetal death (IUFD); total bile acids (TBA); ursodeoxycholic acid (UDCA)
资金
- Ministry of Health of the Czech Republic [IGA MZCR NT 12211-5]
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder of pregnancy. Diagnosis is based on the clinical picture, particularly the presence of pruritus with a deterioration of liver function tests, and typically elevated serum levels of total bile acids. ICP manifests in the second half of pregnancy, predominantly during the third trimester. Symptoms of the disease resolve spontaneously after delivery. Etiology is still not fully understood. Genetic defects in specific transport proteins, elevated levels of sex hormones, and various environmental factors are thought to play a role in the development of this disorder. Although practically benign for the pregnant woman, ICP represents a serious threat to the fetus. It increases the risk of preterm delivery, meconium excretion into the amniotic fluid, respiratory distress syndrome, and sudden intrauterine fetal death. Identifying fetuses at risk of ICP complications remains challenging. The ideal obstetrical management of ICP needs to be definitively determined. The aim of this review is to summarize the current knowledge on fetal complications of ICP and describe management options for their prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据